ilShinBioBase Co

ilShinBioBase Co FCF Yield

The Free Cash Flow Yield of ilShinBioBase Co (068330.KQ) as of Nov 11, 2026 is 8.02 %. In the previous year, Free Cash Flow Yield was 6.22 % — a change of 28.97% (higher).

FCF Yield

8.02 %

YoY

28.97%

Last updated:

Free Cash Flow Yield of ilShinBioBase Co is 2025 8.02 % . Free Cash Flow Yield of ilShinBioBase Co was 2024 6.22 % . It decreases by 28.97% higher compared to the previous year.

The ilShinBioBase Co FCF Yield history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Yield
Date
FCF Yield
Jan 1, 2018
6.87 KRW
Jan 1, 2019
8.11 KRW
Jan 1, 2020
5.52 KRW
Jan 1, 2021
10.10 KRW
Jan 1, 2022
3.25 KRW
Jan 1, 2023
8.66 KRW
Jan 1, 2024
6.22 KRW
Jan 1, 2025
8.02 KRW
The ilShinBioBase Co FCF Yield history
YEARFCF YieldYoY
8.02 %+28.97%
6.22 %-28.17%
8.66 %+166.58%
3.25 %-67.85%
10.10 %+82.96%
5.52 %-31.91%
8.11 %+18.06%
6.87 %+163.09%
2.61 %-37.62%
4.19 %+1,502.03%
0.26 %-94.70%
4.93 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

ilShinBioBase Co Stock analysis

What does ilShinBioBase Co do? ilShinbiobase Co., Ltd. generates revenue by manufacturing and distributing industrial refrigeration equipment. Its product portfolio includes freeze dryers for drying sera, antibiotics, enzymes, laboratory samples, and foods; programmable freeze dryers for early-stage research with temperature, time, and vacuum control; deep freezers for biotechnology applications; and ice makers for research laboratories. The company also offers blood bank refrigerators, pharmaceutical refrigerators, shakers, and food processing equipment. These products are sold domestically and to overseas markets, targeting biotechnology firms, pharmaceutical companies, research institutions, and laboratories requiring specialized refrigeration solutions. The company's revenue streams primarily come from the sale of its industrial refrigeration equipment to customers in the biotechnology, pharmaceutical, and research sectors. Products like programmable freeze dryers and deep freezers are specifically designed for early-stage research and biotechnology applications, catering to the needs of laboratories and biotech firms. Blood bank refrigerators and pharmaceutical refrigerators serve healthcare and pharmaceutical industries, while ice makers and food processing equipment support research and food-related applications. ilShinbiobase’s business model focuses on providing specialized refrigeration equipment for niche markets. The company targets biotechnology and pharmaceutical industries with deep freezers and blood bank refrigerators, while programmable freeze dryers and shakers are marketed to research laboratories. Overseas and domestic distribution channels ensure market reach, with products tailored to specific industry requirements such as serum drying in pharmaceuticals and sample preservation in laboratories. ilShinBioBase Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about ilShinBioBase Co stock

Free Cash Flow Yield of ilShinBioBase Co is 8.02 % in 2025.

Free Cash Flow Yield of ilShinBioBase Co changed from 6.22 % to 8.02 %, representing a 28.97% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow Yield ilShinBioBase Co since 2006 – with annual values, charts, and detailed analysis.

FCF Yield measures the free cash flow per share relative to the stock price. It indicates how much cash a company generates for each dollar invested.

To evaluate Free Cash Flow Yield's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Free Cash Flow Yield.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Free Cash Flow Yield's ilShinBioBase Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — ilShinBioBase Co

All Key Metrics — ilShinBioBase Co